Drug Shortage Report for UROMITEXAN
| Report ID | 155660 |
| Drug Identification Number | 02241411 |
| Brand name | UROMITEXAN |
| Common or Proper name | Uromitexan |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | MESNA |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL INTRAVENOUS ORAL INTRAVENOUS |
| Packaging size | 15 ampoules / box (Product Code: 2639B2010) |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-02-25 |
| Actual start date | 2022-02-25 |
| Estimated end date | 2022-03-30 |
| Actual end date | 2022-03-30 |
| Shortage status | Resolved |
| Updated date | 2022-03-31 |
| Company comments | UROMITEXAN (mesna) Injection 400 mg/4 mL (100mg/mL). Box of 15 ampoules. Baxter code 2639B2019 can be used as a substitute. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2022-03-31 | English | Compare |
| v13 | 2022-03-30 | French | Compare |
| v12 | 2022-03-30 | English | Compare |
| v11 | 2022-03-25 | French | Compare |
| v10 | 2022-03-25 | English | Compare |
| v9 | 2022-03-22 | French | Compare |
| v8 | 2022-03-22 | English | Compare |
| v7 | 2022-03-21 | French | Compare |
| v6 | 2022-03-21 | English | Compare |
| v5 | 2022-03-15 | French | Compare |
| v4 | 2022-03-15 | English | Compare |
| v3 | 2022-02-26 | English | Compare |
| v2 | 2022-02-25 | French | Compare |
| v1 | 2022-02-25 | English | Compare |
Showing 1 to 14 of 14